We describe the fi rst reported case of renal zygomycosis presenting as an isolated fungus ball (bezoar) without renal parenchymal invasion. Since all previous descriptions of renal involvement have discussed tissue invasion, our case is unique in that the infection was confi ned solely in the renal pelvis and extended to the distal ureter without signs of contiguous renal infection. Our patient later developed renal insuffi ciency while receiving amphotericin B Lipid Complex (ABLC). The therapy was changed to posaconazole with subsequent clinical, mycologic, and radiographic improvement and the patient has remained free of recurrence 5 years after diagnosis.
extensive tissue invasion [5, 6] . The case described in this paper differs from those reports of renal zygomycosis in the literature by the agent ' s location strictly within the renal collecting system with no evidence of parenchymal invasion.
Renal fungus balls are typically due to Candida spp. and occur most commonly among neonates and patients with immune dysfunction such as those with DM, AIDS, or solid organ transplant recipients. Moulds, including Aspergillus spp., have also been shown to cause renal fungus balls and the management of these lesions typically includes a combined surgical and medical approach with systemic antifungal agents [7 -9] . To our knowledge, a renal fungus ball secondary to zygomycosis without concurrent tissue invasion has not been previously reported.
Infection with one of the mucormycetes (formerly zygomycetes) is typically managed with an amphotericin B formulation and surgical resection, if feasible, of involved tissue. However, these infections often require prolonged antifungal therapy placing patients at risk for medicationinduced side effects. Posaconazole is a new extended-spectrum azole antifungal that has demonstrated in vitro and in vivo activity against the mucormycetes [10] . It may have lower MICs when tested against Rhizopus spp. than amphotericin B but has been used successfully in the past as salvage
Introduction
Zygomycosis is an uncommon infection that may cause a variety of manifestations particularly in immunocompromised patients and those with diabetes mellitus. Although invasive fungal infections caused by zygomycetes are rare, recent publications have suggested an increasing incidence over the last decade [1] . Traditional risk factors for zygomycosis include metabolic acidosis, corticosteroid use, hematologic malignancies, organ transplantation, iron overload, diabetes mellitus (DM), intravenous drug use (IVDU) and acquired immunodefi ciency syndrome (AIDS) -all comorbid conditions that may have also increased in frequency over the past 10 years [2] . However, DM is the most common predisposing etiology described in a recent review [3] . The most frequent clinical presentations of infection include; rhinocerebral, pulmonary, disseminated, gastrointestinal, or cutaneous disease [4] . Renal zygomycosis remains rare and is generally a complication of disseminated disease with evidence of therapy during infection with these diffi cult pathogens [11] . Posaconazole is an attractive regimen due to its; (1) favorable safety profi le even with long-term therapy, (2) typically low MICs against Rhizopus spp., and (3) availability of an oral formulation [12] .
Herein we report the novel presentation of an isolated Rhizopus oryzae fungus ball, and highlight the successful use of posaconazole as salvage therapy in combination with surgical drainage to avoid nephrectomy.
Case report
A 32-year-old male with a history of diabetes mellitus and IVDU presented with a two-month history of hematuria associated with right fl ank pain, oliguria, and 45 kg weight loss. He denied fevers, chills, night sweats, or dysuria. He described the inability to urinate although with continued straining he was able to pass multiple fragments of tan-brown necrotic tissue followed by gross hematuria. The patient described these as 4 -5 inch long pieces of tissue that resembled ' cigarettes ' . Samples were collected and sent to pathology, and were later found to be consistent with a fungus ball ( Fig. 1) .
On admission the patient had a temperature of 98.6º F, pulse of 96 per minute and a blood pressure of 128/80 mmHg. He was in no distress, and his nasal mucosa and oropharynx appeared normal. Cardiac, pulmonary and abdominal examinations were unremarkable. However he exhibited mild pain to palpation over his right iliac fossa without evidence of peritoneal irritation, and no costovertebral angle tenderness. His admission laboratory values included; white blood cell count 5,000 cells/ul, hemoglobin 6.8 gm/dl, hematocrit 19.8% (MVC 79.9), platelet count 132,000 cells/ul. His renal function and anion gap were normal. His serum glucose and hemoglobin A 1 C were 227 mg/dl and 14.1, respectively. Testing for the human immunodefi ciency virus (HIV) was negative. Chemical and microscopic analysis of the patient ' s urine revealed yellow-hazy urine with 1 ϩ protein, 3 ϩ glucose, 3 ϩ blood, negative nitrites, 1 ϩ leukocyte esterase, 10 -25 WBC/HPF, 25 -50 RBC/HPF, and rare bacteria. His urine drug screen was positive for cocaine. An intravenous pyelogram was performed (Fig. 2) showing fi lling defects within the renal pelvis.
The patient underwent cystoureteroscopy with partial extraction of a ' large yellow fl uffy appearing mass ' extending from the distal ureter towards the renal pelvis. A nephrostomy tube was subsequently placed and oral therapy with fl uconazole started at 200 mg daily. No evidence of bladder involvement was noted. Percutaneous renal endoscopy was performed (Fig. 3) 2 days later resulting in the further removal of a large bladder fungal bezoar and change of the nephrostomy tube. Cultures from this material grew Rhizopus oryzae the following day and histopathology was consistent with this diagnosis as well.
The isolate was identifi ed as Rhizopus oryzae based upon macroscopic, microscopic, and physiologic features and is accessioned into the Fungus Testing Laboratory stock collection as UTHSC 05-812. Pale gray colonies with a white reverse grew rapidly at 25 ° C, fi lling the Petri dish in 3 days. Mature sporangia were seen as black dots on the aerial hyphae. Microscopic features included wide (6 -10 μ m), sparsely-septate hyaline hyphae, long sporangiophores with nodal rhizoids, some of which were attached to the lid of the Petri dish, globose sporangia, and angular, longitudinally striate sporangiospores measuring 4 ϫ 6 μ m. Temperature studies demonstrated good growth at 37 ° C and reduced growth at 40 ° C. Rhizopus microsporus was eliminated from consideration based upon colonial height, length of sporangiophores, the morphology of the sporangiospores, and reduced growth at 40 ° C. The mean inhibitory concentration for posaconazole and amphotericin B deoxycholate were 2.0 and 0.25 μ g/ml, respectively.
Fluconazole was stopped and amphotericin B lipid complex 350 mg (5mg/kg) and amphotericin B deoxycholate 50 mg/l of water were instilled through the nephrostomy tube every 8 h. The patient tolerated this treatment well and on day 9 of hospitalization amphotericin B instillation through his nephrostomy tube was discontinued as he left against medical advice. The patient did, however, continue amphotericin B lipid complex 350 mg IV daily. His creatinine increased to 1.9 mg/dL after 4 weeks of therapy. MRI at this time showed only indeterminate non-enhancing punctate foci in the inferior pole, without evidence of abscess or pyelonephritis. His therapy was changed to posaconazole 400 mg orally twice daily to complete six months of therapy. The patient has had no signs or symptoms of recurrence and has been free of antifungal medications for 5 years. and negative urine cultures. However this diagnosis is not often clinically suspected prior to surgical resection or postmortem examinations due to the rarity of this manifestation of disease. Our case differs signifi cantly from those in the literature due to the presence of an isolated fungal bezoar (fungus ball) without evidence of invasive disease. This manifestation has not been previously reported with respect to the mucormycetes. Renal fungus balls are almost uniformly secondary to Candida spp. infections and are most commonly observed in neonates [14] . These cases are presumed to occur through hematogenous seeding or via ascending infection from the lower genitourinary tract [8, 9] . However, Candida fungus balls have also been described in diabetics, transplant patients, those with HIV, or more rarely in the elderly without obvious underlying immunosuppression. Aspergillus spp. have also been implicated as a cause of renal fungal balls although these cases are quite uncommon [15, 16] .
The pathologic fi ndings within a renal fungus ball differ signifi cantly from those in pulmonary fungus balls caused by the mucormycetes or Aspergillus spp. Fruiting bodies develop from mycelia in areas of high oxygen tension, such as lung/or sinus cavities, and consequently, do not develop in tissues. Thus, the pathologic fi ndings associated with a renal mycetoma are considerably different from those found with a mycetoma within the lung, even though both may be caused by the same fungus.
Therapy advocated for bezoars caused by these pathogens usually involves a combined medical and surgical approach [14] . The majority of existing data relates to fungal balls caused by Candida spp. and previous publications suggest the early initiation of systemic antifungal therapy prior to surgical manipulation of the genitourinary tract so as to avoid hematogenous dissemination. Irrigation of amphotericin B deoxycholate (50mg/l of sterile water) via the catheter or
Discussion
Mucormycetes (formerly zygomycetes) include the genera Rhizopus , Lichtheimia (formerly Absidia ), Apophysomyces , Cunninghamella , Saksenaea , Rhizomucor , and Mucor amongst others [2] . These pathogens have a worldwide distribution and infection can be acquired though inhalation, ingestion, cutaneous exposure, contamination of wounds, trauma, or injection [2] . Renal zygomycosis is presumed to occur via seeding of the kidneys during an episode of fungemia. Isolated renal zygomycosis is rare and patients usually have well recognized risk factors for fungemia, including an intravenous catheter, intravenous drug use, alcoholism, corticosteroid therapy, or infection with the human immunodefi ciency virus [13] .
Patients with renal zygomycosis typically present with fever, fl ank pain (may be unilateral or bilateral depending upon the extent of disease), hematuria, urinary obstruction, nephrostomy tube has also been recommended [14] . Balloon dilatation of infl ammatory strictures may be required to reestablish drainage through the ureters and some infections will need open pyelotomy for debridement. Percutaneous resection of the fungus ball has also been suggested during the treatment of Candida associated bezoars. Although there are no previous reports of the mucormycetes causing renal fungus balls without renal parenchymal involvement, infections caused by these agents at other sites typically mandates debridement given their high mortality (up to 50%) and frequent poor response to antifungal therapy [3] . Our patient was asymptomatic aside from his intermittent urinary obstruction and his laboratory and radiographic fi ndings were not suggestive of an invasive infection. For this reason we opted to avoid nephrectomy and attempted systemic antifungal therapy and resection of the fungus ball through percutaneous endoscopy. The mechanism of infection was presumed to be the result of his intravenous drug abuse. Inoculation via this mechanism seems feasible and heroin abuse has been associated with transient but signifi cant leukopenia which may have further predisposed our patient [17] . However with an otherwise intact immune system direct tissue invasion did not occur, although this remains hypothetical.
The patient tolerated 4 weeks of ABLC and at that time his therapy was changed to posaconazole. Oral posaconazole has been used as salvage therapy for patients with zygomycosis who are unresponsive or intolerant of amphotericin B and has a reported success rate of 79% in one recent study [18] . Another similar investigation evaluating posaconazole as salvage therapy in 91 patients with zygomycosis reported a success rate of 60% at 12 weeks and 21% of patients had stable disease [19] . Despite the lack of tissue invasion a longer course of an amphotericin B formulation was chosen given the relatively low renal clearance of posaconazole (13% of total drug is excreted in the urine [20] .
In conclusion although fungal bezoars caused by nonCandida spp. remain rare, a similar approach as used in the treatment of Candida fungus balls may yield satisfactory results in patients without evidence of tissue invasion. In this case we have shown that a combined minimally invasive surgical approach and an amphotericin B formulation followed by long-term posaconazole may provide effective and curative therapy.
